Search results
Found 55 matches for
Usama Ali, medical statistician at the Centre for Statistics in Medicine (CSM) wowed the crowd at the Royal Statistical Society’s (RSS) 2017 Young Statisticians Meeting, winning best presentation for his work preventing falls in hospitals.
COVID-19 vaccines effectiveness: results from Norway demonstrate the reproducibility of federated analytics
Botnar Coronavirus COVID-19 Main Statistics and epidemiology
11 April 2024
Researchers from NDORMS and the University of Oslo, have successfully replicated findings from recently published international studies on the effectiveness of COVID-19 vaccines to prevent long COVID and post-acute complications.
New study reveals long-term mental health risks after COVID-19
Botnar Coronavirus COVID-19 Main Statistics and epidemiology
21 March 2024
A new study published in Nature Human Behaviour sheds light on the long-term mental health consequences of COVID-19 infection and the growing evidence of the protective effect of vaccination on reducing the risk.
COVID jab linked to lower risk of COVID-19-related clot and heart complications
Botnar Main Statistics and epidemiology
13 March 2024
NDORMS research shows that vaccination reduced the risk of heart failure and some clot-related complications for up to a year.
Removing bias from healthcare AI tools
Botnar Main Research Statistics and epidemiology
22 February 2024
Rapid advances in Artificial Intelligence (AI) have opened the way for the creation of a huge range of new healthcare tools, but to ensure that these tools do not exacerbate preexisting health inequities, researchers urge the use of more representative data in their development.
COVID-19 vaccines found effective in reducing long COVID symptoms
Botnar Coronavirus COVID-19 Main Statistics and epidemiology
12 January 2024
A recent study has revealed the effectiveness of COVID-19 vaccines in preventing long COVID.
DARWIN EU® success leads to expansion
Botnar Main Statistics and epidemiology
3 May 2023
The European Medicines Agency (EMA) initiative DARWIN EU® has completed its first studies and is calling for new data partners
Data-Driven research will map COVID-19 vaccine effectiveness in Brazil and Pakistan
Funding Main Statistics and epidemiology
5 April 2023
A study to monitor the safety and effectiveness of the COVID-19 vaccine in the Global South, has received funding from the Bill & Melinda Gates Foundation’s Grand Challenges initiative.
Jonathan Cook elected as Society for Clinical Trials board member
CSM Main OCTRU Statistics and epidemiology
3 April 2023
Associate Professor Jonathan Cook has been elected to the Society for Clinical Trials (SCT) board.
NIHR Fellowships awarded to NDORMS researchers
CSM Main Statistics and epidemiology
17 March 2023
Congratulations to Eileen Morrow and Mae Chester-Jones who have received NIHR Doctoral Fellowships
OCTRU - delivering answers to important clinical questions
CSM Main OCTRU Orthopaedics and trauma RRIO SITU Statistics and epidemiology
7 March 2023
The Oxford Clinical Trials Research Unit (OCTRU) has received NIHR benchmarking results and offers excellent value for money according to the report
New cost-benefit model of Fracture Liaison Services helping healthcare decision makers
Main Statistics and epidemiology
9 February 2023
The newly developed model to estimate the health benefits and budget impact of Fracture Liaison Services (FLS) finds them highly effective in shaping positive patient outcomes, and will help drive policy decisions.
Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination
Coronavirus COVID-19 Main Statistics and epidemiology
28 October 2022
Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.
Higher risk of blood clots in COVID-19 outpatients, largely reduced after vaccination
CSM Coronavirus COVID-19 Main Statistics and epidemiology
19 August 2022
Researchers at NDORMS have studied the association between ambulatory COVID-19 and short-term risk of venal thrombosis and the clinical and genetic risk factors predisposing them to developing post–COVID-19 thrombosis.
OCTRU collaboration boosts understanding of COVID vaccine response
Coronavirus COVID-19 Main Statistics and epidemiology
21 July 2022
Working with researchers across multiple universities, the Oxford Clinical Trials Unit (OCTRU) played a key role in delivering results of the national VROOM trial (Vaccine Response On Off Methotrexate).
COVID-19’s high blood clot risk
Coronavirus COVID-19 Main Statistics and epidemiology
14 May 2022
A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.
Oxford leads global cross-collaboration Covid research
Botnar Coronavirus COVID-19 Main Statistics and epidemiology
14 March 2022
A new collaboration between Oxford, Brazil and Pakistan has been funded by the Bill & Melinda Gates Foundation. The partnership will provide researchers with de-identified health data from two of the worlds global COVID-19 hotspots to increase understanding of COVID-19 in these communities and help accelerate the management of the disease.
NDORMS joins DARWIN EU® Coordination Centre for drug and vaccine safety
CSM Main Statistics and epidemiology
11 February 2022
The European Medicines Agency has announced the establishment of the Data Analysis and Real World Interrogation Network (DARWIN EU®) to support better decision making on the development and effectiveness of medicines and vaccines.
Vaccination safety: generating accurate evidence is the clearest path to creating public trust
Botnar CSM Main Statistics and epidemiology
25 November 2021
A new study shows that a vaccine surveillance method in observational data may generate high number of false positives
New advanced analytics research to deliver next level of insights into COVID-19
CSM Coronavirus COVID-19 Funding Main Statistics and epidemiology
11 November 2021
NDORMS is leading one of nine new studies awarded total of £2m to use large-scale linked data to address priority research questions that will improve understanding of the pandemic and inform the continued policy response.
Oxford researchers call for an urgent re-evaluation of “weak” opioid safety profile
Main Statistics and epidemiology
22 October 2021
A new study associates dispensation doses of tramadol with increased risk of mortality, cardiovascular events, and fractures compared to the use of codeine to treat pain.